Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

CD2 might be a new treatment target for patchy alopecia areata.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Higher CRBP1 levels are linked to more severe alopecia areata.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Pantethine may boost the immune system's ability to fight sarcoma.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Four specific genes are linked to keloid formation and could be potential treatment targets.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Exosomes could be effective for improving skin health and treating skin diseases.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.